Welcome to the Kids' Library!

Assessing the impact of a safe and equitable biosimilar policy in the United States hearing before t

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health.
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2008. 2008

Closing the coverage gap Medicare prescription drugs are becoming more affordable.

[Baltimore, Maryland] : Centers for Medicare & Medicaid Services, [2015] 2015

Closing the gaps in Hatch-Waxman : assuring greater access to affordable pharmaceuticals : hearing b

United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions.
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O. [Congressional Sales Office], 2002. 2002

Examining the Senate and House versions of the "Greater Access to Affordable Pharmaceuticals Act" :

United States. Congress. Senate. Committee on the Judiciary.
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2004. 2004

Generic drug entry prior to patent expiration : an FTC study

United States. Federal Trade Commission.
[Washington, D.C.] : Federal Trade Commission, [2002] 2002

The generic drug maze : speeding access to affordable life-saving drugs : hearing before the Special

United States. Congress. Senate. Special Committee on Aging.
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2006. 2006

Generic drugs needs and issues

New York : Nova Science Publishers, 2009. 2009

Greater access to generic drugs

Meadows, Michelle.
[Rockville, Md. : Dept. of Health and Human Services, Food and Drug Administration, 2004] 2004

Guidance for industry 180-day generic drug exclusivity under the Hatch-Waxman amendments to the Fede

Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, [1998] 1998

Increasing generic drug use savings for seniors and Medicare : hearing before the Special Committee

United States. Congress. Senate. Special Committee on Aging.
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2007. 2007

The law of biologic medicine : hearing before the Committee on the Judiciary, United States Senate,

United States. Congress. Senate. Committee on the Judiciary.
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2004. 2004

Perspectives of drug manufacturers : abbreviated new drug applications.

United States. Department of Health and Human Services. Office of Inspector General. Office of Evaluation and Inspections, author.
[Washington, D.C.] : Department of Health and Human Services, Office of Inspector General, Office of Evaluation and Inspections, 1990. 1990

Preserve Access to Affordable Generics and Biosimilars Act : report together with additional views (

United States. Congress. House. Committee on the Judiciary, author.
[Washington, D.C.] : [U. S. Government Publishing Office], 2020- 2020

Proposed FDA user fee acts: Generic Drug User Fee Amendments of 2012 (GDUFA) and Biosimilar User Fee

Thaul, Susan, author.
[Washington, D.C.] : Congressional Research Service, 2019- 2019

Recent developments which may impact consumer access to, and demand for, pharmaceuticals : hearing b

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health.
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., [Congressional Sales Office], 2001. 2001

Risk evaluation and mitigation strategies (REMS) and generic drugs

Bodie, Agata, author.
[Washington, D.C.] : Congressional Research Service, 2018- 2018

Safe and affordable biotech drugs : the need for a generic pathway : hearing before the Committee on

United States. Congress. House. Committee on Oversight and Government Reform.
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2008. 2008

Special report of the U.S. Senate Special Committee on Aging on the sudden price spikes in off-paten

United States. Congress. Senate. Special Committee on Aging, author.
Washington : U.S. Government Publishing Office, 2016. 2016

Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics Act : report

United States. Congress. House. Committee on the Judiciary, author.
[Washington, D.C.] : [U. S. Government Publishing Office], 2020. 2020